Skip to main content

Table 3 Clinical outcomes data by group

From: Effectiveness of saline water and lidocaine injection treatment of intractable plantar keratoma: a randomised feasibility study

  Group 1 Group 2 Group 3 Group 4
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
n = 10 at baseline n = 10 at baseline n = 10 at baseline n = 10 at baseline
VAS Baseline 4.8 (2.1) 3.7 (2.0) 4.2 (2.9) 3.5 (3.0)
(0–10) T2 1.9 (2.6) 1.7 (2.3) 1.0 (1.6) 1.7 (2.3)
  T3 2.6 (3.0) 1.2 (2.1) 0.7 (1.3) 1.2 (2.3)
  T4 2.8 (3.0) 0.2 (0.3) 0.6 (1.4) 1.2 (2.3)
  T6 4.0 (3.6) 3.1 (3.0) 2.2 (3.1) 1.2 (2.3)
  T12 5.3 (3.7) 1.8 (2.7) 2.2 (2.4) 2.7 (2.8)
FFI-R Baseline 68.8 (17.1) 57.8 (29.4) 69.6 (34.7) 53.4 (29.6)
(/270) T2 45.1 (20.9) 45.1 (26.2) 37.3 (25.8) 37.1 (22.9)
  T3 51.1 (37.1) 30.1 (11.7) 32.4 (22.6) 32.6 (23.4)
  T4 41.2 (23.7) 28.5 (13.7) 31.1 (24.8) 32.5 (23.4)
  T6 54.1 (41.9) 34.4 (21.9) 46.3 (42.4) 31.9 (23.6)
  T12 63.5 (48.5) 37.7 (22.9) 33.3 (14.0) 34.4 (22.7)
IPK’s Width Baseline 3.4 (1.6) 3.3 (2.7) 3.1 (1.6) 2.0 (1.5)
(mm) T2 2.8 (0.9) 2.1 (1.3) 2.8 (2.6) 2.1 (0.9)
  T3 2.1 (0.9) 1.7 (1.5) 2.5 (3.4) 1.4 (1.4)
  T4 2.1 (1.4) 1.9 (1.6) 0.9 (1.1) 1.4 (1.4)
IPK’s Length Baseline 2.7 (1.0) 2.9 (2.7) 3.4 (2.2) 2.5 (1.5)
(mm) T2 2.7 (1.0) 2.1 (1.6) 2.8 (2.6) 2.1 (1.2)
  T3 2.5 (1.1) 1.9 (1.4) 3.0 (4.1) 1.6 (1.6)
  T4 2.3 (1.5) 1.8 (1.4) 1.1 (1.5) 1.6 (1.6)
IPK’s Depth Baseline 1.7 (0.7) 1.7 (0.8) 1.7 (0.6) 1.5 (0.9)
(mm) T2 1.4 (0.5) 1.1 (0.9) 0.8 (0.4) 1.0 (0.7)
  T3 0.9 (0.1) 0.8 (0.7) 0.3 (0.3) 0.7 (0.8)
  T4 1.0 (0.7) 0.8 (0.6) 0.3 (0.4) 0.7 (0.8)
  1. VAS Visual analog scale; FFI-R Foot Function Index-Revised; IPK Intractable Plantar Keratoma; SD Standard Deviation; mm: millimeter; T2 intervention at 4-week; T3 intervention at 8-week; T4 intervention at 12-week; T6 6-month follow-up; T12 12-month follow-up